IP Library Granted Patent US 9,243,221
Granted Patent B2
US 9,243,221 · App. 13/131,041 · Granted Jan 26, 2016

Compositions and methods of functionally enhanced in vitro cell culture system

Inventors: Martin Yarmush (Newton, MA); Robert Freedman (Beverly Hills, CA); Yaakov Nahmias (Plymouth, MN); Eric Novik (Edison, NJ)
Assignees: HUREL CORPORATION; THE GENERAL HOSPITAL CORPORATION
C12M35/08C12M23/12C12M23/16C12M25/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,243,221
App. No.
13/131,041
Granted
Jan 26, 2016
Kind
B2
Abstract

Compositions and methods described herein provide a cell culture system in which cells are in high metabolic states from the onset of the culture. Combinations of various cell culture components disclosed and employed herein allow cells to be in high metabolic states useful for drug testing immediately after the start of cell culture.

Claims (34)

1. A cell culture system, comprising:

a) a cell culture compartment comprising a cell culture substrate and a cell culture medium comprising no more than about 10% serum;

b) a coculture of metabolically active primary hepatocytes and at least one other cell type, said coculture seeded onto the culture substrate and cultured in the culture medium; and

c) a gaseous composition in contact with the culture medium and comprising at least about 90% oxygen.

2. The cell culture system of claim 1 , wherein the culture medium comprises no more than about 5% serum.

3. The cell culture system of claim 1 , wherein the culture medium is serum free.

4. The cell culture system of claim 1 , wherein the at least one other cell type is a stromal cell type.

5. The cell culture system of claim 1 , wherein the at least one other cell type is a non-parenchymal cell type.

6. The cell culture system of claim 1 , wherein the ratio of the number of metabolically active primary hepatocytes to the number of cells of the at least one other cell type in the coculture is from about 1:10 to about 10:1.

7. The cell culture system of claim 1 , wherein the ratio of the number of metabolically active primary hepatocytes to the number of cells of the at least one other cell type in the coculture is from about 1:5 to about 5:1.

8. The cell culture system of claim 1 , wherein the gaseous composition in contact with the culture medium comprises at least about 95% oxygen.

9. The cell culture system of claim 1 , wherein the gaseous composition in contact with the culture medium comprises at least about 100% oxygen.

10. The cell culture system of claim 1 , wherein the coculture of metabolically active primary hepatocytes and the at least one other cell type are seeded into the culture compartment and cultured in the culture medium in contact with the gaseous composition for about one day.

11. The cell culture system of claim 10 , wherein following culturing in the culture medium in contact with the gaseous composition for about one day the level of albumin secretion by hepatocytes in the coculture is at least about 4-fold higher than the level of albumin secretion by hepatocytes in a control coculture comprising a gaseous composition in contact with the culture medium and comprising an atmospheric level of oxygen.

12. The cell culture system of claim 10 , wherein the level of albumin secretion by hepatocytes in the coculture is at least about 80 μg/1×10 6 cells /24 hrs.

13. The cell culture system of claim 10 , wherein the level of transcription of phase I and phase II enzymes in hepatocytes in the coculture is comparable to the level of transcription of phase I and phase II enzymes in freshly isolated hepatocytes.

14. The cell culture system of claim 10 , wherein the CYP1A1/2 activity level of hepatocytes in the coculture is comparable to the CYP1A1/2 activity level in freshly isolated hepatocytes.

15. A cell culture system made by a method comprising:

a) seeding a coculture of metabolically active primary hepatocytes and at least one other cell type onto a culture substrate; and

b) culturing the seeded coculture in a culture medium comprising no more than about 10% serum;

wherein during the seeding and/or culturing the culture medium is in contact with a gaseous composition comprising at least about 90% oxygen.

16. The cell culture system of claim 15 , wherein the culturing is for from about one to about three days.

17. The cell culture system of claim 15 , wherein the culture medium comprising no more than about 5% serum.

18. The cell culture system of claim 15 , wherein the culture medium is serum free.

19. The cell culture system of claim 15 , wherein the gaseous composition comprises at least about 95% oxygen.

20. The cell culture system of claim 15 , wherein the gaseous composition comprises at least about 100% oxygen.

21. A cell culture system, comprising:

a) a cell culture compartment comprising a cell culture substrate and a cell culture medium comprising no more than about 10% serum;

b) a coculture of metabolically active primary hepatocytes and at least one other cell type, said coculture seeded onto the culture substrate and cultured in the culture medium, wherein during the seeding and/or the first one to three days of culturing the culture medium is in contact with a gaseous composition comprising at least about 90% oxygen; and

c) a gaseous composition in contact with the culture medium and comprising at least about 90% oxygen;

wherein the level of albumin secretion by hepatocytes in the coculture is at least about 4-fold higher than the level of albumin secretion by hepatocytes in a control coculture comprising a gaseous composition in contact with the culture medium and comprising an atmospheric level of oxygen.

22. The cell culture system of claim 21 , wherein the level of albumin secretion by hepatocytes in the coculture is at least about 80 μg/1×10 6 cells /24 hrs.

23. The cell culture system of claim 21 , wherein the level of transcription of phase I and phase II enzymes in hepatocytes in the coculture is comparable to the level of transcription of phase I and phase II enzymes in freshly isolated hepatocytes.

24. The cell culture system of claim 21 , wherein the CYP1A1/2 activity level of hepatocytes in the coculture is comparable to the CYP1A1/2 activity level in freshly isolated hepatocytes.

Assignments (4)
SECURITY INTEREST Recorded Apr 21, 2021
From: HUREL CORPORATION
To: FREEDMAN, ROBERT
Reel/Frame 055999/0001 →
CONFIRMATORY LICENSE Recorded Sep 12, 2013
From: THE GENERAL HOSPITAL CORPORATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031208/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2011
From: YARMUSH, MARTIN; NAHMIAS, YAAKOV
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 026890/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2011
From: FREEDMAN, ROBERT; NOVIK, ERIK
To: HUREL CORPORATION
Reel/Frame 026890/0626 →
Continuity (2)
Provisional Application 61118362 · Nov 26, 2008
Related Publication 20120129207A1 · May 24, 2012